Earnings Call · Q3 FY2023·2023-11-02

Q3 23EPS -2.52%·Rev n/aQ2 23EPS -21.85%·Rev n/aQ1 23EPS -23.26%·Rev n/aQ4 22EPS -94.87%·Rev n/a⚠ consensus missing

Vir Biotechnology, Inc. VIR

Sasha Damouni Ellis — Investor Relations or Communications

Marianne De Backer — Chief Executive Officer

Phil Pang — Chief Medical Officer

Sung Lee — Chief Financial Officer

+7.0%1d on move date+6.0% vs SPY3d+3.1%5d−0.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more VIR calls or request research access.

More VIR calls Browse calls Request research access